October 18, 2023
The Honorable Patrick McHenry | The Honorable Hakeem Jeffries |
Speaker Pro Tempore | Democratic Leader |
U.S. House of Representatives | U.S. House of Representatives |
H-232, The Capitol | H-204, The Capitol |
Washington, DC 20515 | Washington, DC 20515 |
The Honorable Charles Schumer | The Honorable Mitch McConnell |
Majority Leader | Republican Leader |
U.S. Senate | U.S. Senate |
S-221, The Capitol | S-230, The Capitol |
Washington, DC 20510 | Washington, DC |
Re: Extend Medicare Advanced Alternative Payment Model Incentive Payments
Dear Speaker Pro Tempore McHenry, Leader Jeffries, Leader Schumer, and Leader McConnell:
On behalf of the 23 undersigned physician and health care associations and over 600 health systems, hospitals, physician practices, health clinics, and accountable care organizations (ACOs), thank you for your leadership in ensuring that physicians and other clinicians have adequate resources to care for the health of the U.S. population. As Congress considers priority end-of-year legislation, we ask that you bolster and advance the ongoing transition to value-based payment models by extending the 5 percent advanced alternative payment model (APM) incentive payments for clinicians that were authorized under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Eight years ago, Congress passed MACRA to shift how Medicare pays clinicians for health care services. Key goals were to encourage keeping patients healthy, reducing unnecessary care, and lowering costs for both patients and taxpayers. APMs have demonstrated that when physicians and other clinicians are held accountable for costs and quality and provided flexibility from fee-for-service (FFS) constraints, they can generate savings for taxpayers and improve beneficiary care.
Recognizing that FFS payments alone are not sufficient to cover the expenses associated with building and maintaining the necessary infrastructure to engage in wholescale care delivery redesign, MACRA included 5 percent incentive payments to enable clinicians to transition to advanced APMs (i.e., down-side risk APMs). This strategy has proven successful as participation in advanced APMs has grown by more than 173 percent with nearly 300,000 clinicians.